Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability

International Journal of Cancer

Volumn 65, Issue 6, 1996, Pages 812-820

  Guerra, Fabiana K ^a   Eijan, Ana Maria ^c   Puricelli, Lydia ^c   Alonso, Daniel F ^c   De Kier Joffé, Elisa Bal ^c   Kornblihtt, Alberto R ^b   Charreau, Eduardo H ^a   Elizalde, Patricia V ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^c Animal Care and Experimental Cancer Research   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; FEMALE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029960090     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960315)65:6<812::AID-IJC18>3.0.CO;2-5     Document Type: Article

References (48)

1. ALONSO, D.F., FARIAS, E.F. and BAL DE KIER JOFFE, E., Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas. Cancer Lett., 70, 181-187 (1993).
2. ARTEAGA, C.L., KITTEN, L.J., CORONADO, E.B., JACOBS, S., KULL, F.C. JR., ALLRFD, D.C. and OSBORNE, C.K., Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. clin. Invest., 84, 1418-1423 (1989).
3. ARTEAGA, C.L. and OSBORNE, C.K., Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res., 49, 6237-6241 (1989).
4. BAL DE KIER JOFFE, E., PURICELLI, L. and LUSTIG, E.S., Modified adhesion behaviour after in vitro passage of two related murine mammary adenocarcinomas with different metastasizing ability. Invasion Metastasis. 6, 302-312 (1986).
5. BAKER, J., LIU, J.P., ROBERTSON, E.J. and EFSTRATIADIS, A., Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75, 73-82 (1993).
6. BARENTON, B., PATE, B., KHAN, M.N., GUYDA, H.J. and POSNER, B.I., Insulin-like growth factor-binding proteins in hypophysectomized rat liver: characterization and subcellular localization. Endocrinology, 122, 2499-2507 (1988).
7. BASERGA, R., The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55, 249-252 (1995).
8. BRUNNER, N., MOSER, C., CLARKE, R. and CULLEN, K.J., IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence. Breast Cancer Res. Treat., 22, 39-45 (1992).
9. BRUNNER, N., YEE, D., KERN, F.G., SPANG-THOMPSEN, M., LIPPMAN, M.E. and CULLEN, K.J., Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to specific down-regulation of insulin-like growth factor II. Europ. J. Cancer, 29A, 562-569 (1993).
10. CHIRGWIN, J., PRYZBYLA, A., MCDONALD, R. and RUTTER, W., Isolation of biologically active ribonucleic acid from sources enriched for ribonuclease. Biochemistry. 18, 5294-5298 (1979).
11. CHRISTOFORI, G., NAIK, P. and HANAHAN, D., A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369, 414-417 (1994).
12. CULLEN, K.J., LIPPMAN, M.E., CHOW, D., HILL, S., ROSEN, N. and ZWIEBEL, J.A., Insulin-like growth factor II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol., 6, 91-100 (1992).
13. CULLEN, K.J., SMITH, H.S., HILL, S., ROSEN, N. and LIPPMAN, M.E., Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res., 51, 4978-4985 (1991).
14. CULLEN, K.J., YEE, D., SLY, W.S., PERDUE, J., HAMPTON, B., LIPPMAN, M.E. and ROSEN, N., Insulin-like growth factor receptor expression and function in human breast cancer Cancer Res., 50, 48-53 (1990).
15. EL-BADRY, O.M., MINNITI, C., KOHN, E.C., HOUGHTON, P.J., DAUGHADAY, W.H. and HELMAN, L.J., Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Diff., 1, 325-331 (1990).
16. FURLANETTO, R.W., Di CARLO, S.N. and WISETTAR, T.C., The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J clin. Endocrinol., 64, 1142-1149 (1987).
17. GAI, X., RIZZO, M.G., LEE, J., ULLRICH, A. and BASERGA, R., Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-I genes. Oncogene Res., 3, 377-386 (1988).
18. GRANELLI-PIPERNO, A. and REICH, E., A study of protease and proteinase inhibitor complexes in biological fluids. J. exp. Med., 146, 223-234 (1978).
19. HARI, J., PIERCE, S.B., MORGAN, D.O., SARA, V., SMITH, M.C. and ROTH, R.A., The receptor for insulin-like growth factor II mediates an insulin-like response. EMBO J., 6, 3367-3371 (1987).
20. HSU, C.J. and HAMMOND, J.M., Gonadotropins and estradiol stimulate immunoreactive insulin-like growth factor-I production by porcine granulosa cells in vitro. Endocrinology, 120, 198-207 (1987).
21. KALEKO, M., RUTTER, W.J. and MILLER, A.D., Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. cell. Biol., 10, 464-473 (1990).
22. KERBEL, R.S., Growth dominance of the metastatic cancer cell:cellular and molecular aspects. Adv. Cancer Res., 55, 87-132 (1990).
23. KIESS, W., THOMAS, C.L., GREENSTEIN, L.A., LEE, L., SKLAR, M.M., RECHLER, M.M, SAHAGIAN, G.G. and NISSLEY, S.P., Insulin-like growth factor II (IGF-II) inhibits both the cellular uptake of β-galactosidase and the binding of β-galactosidase to purified IGF-II/mannose 6-phosphate receptor. J. biol. Chem., 264, 4710-4714 (1989).
24. KOENUMA, M., YAMORI, T. and TSURUO, T., Insulin and insulin-like growth factor I stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn. J. Cancer Res., 80, 51-58 (1989).
25. KORC-GRODZICKI, B., FURLANETTO, R.W. and HILF, R., Characterization of the insulin-like growth factor receptors in the insulin-responsive R3230 sc mammary adenocarcinoma. Oncol. Res. 4, 109-119 (1992).
26. KOSCIELNIAK, E.B., GUTBROD, R., BLUM, W., HENNE, T. and TREUNER, J., Varying patterns of secretion of insulin like growth factors (IGFs) and their binding proteins (BPs) by sarcoma cell lines. Proc. Amer. Assoc. Cancer Res., 35, 44 (1994).
27. LABARCA, C. and PAIYEN, K., A simple, rapid and sensitive DNA assay procedure. Anal. Biochem., 102, 344-352 (1980).
28. 4. Nature (Lond.), 227, 680-685 (1970).
29. LAIHO, M. and KESKI-OJA, J., Growth factors in the regulation of periceliular proteolysis: a review. Cancer Res., 49, 2533-2553 (1989).
30. LIU, J.P., BAKER, J., PERKINS, A.S., ROBERTSON, E.J. and EFSTRATIADIS, A., Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (Igf1r). Cell, 75, 59-72 (1993).
31. LONG, L., RUBIN, R., BASERGA, R. and BRODT, P., Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55, 1006-1009 (1995).
32. MATHIEU, M., ROCHEFORT, H., BARENTON, B., PREBOIS, C. and VIGNON, F., Interactions of cathepsin D and IGF-II on the IGF-II/ M6P receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol. Endocrinol., 4, 1327-1335 (1990).
33. MATHIEU, M., VIGNON, F., CAPONY, F. and ROCHEFORT, H., Estradiol down-regulates the mannose-6-phosphate/IGF-II receptor gene and induces cathepsin D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Mol. Endocrinol., 5, 815-822 (1991).
34. MOLINOLO, A.A., LANARI, C., CHARREAU, E.H., SAN JUAN, N. and DOSNE PASQUALINI, C., Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J. nat. Cancer Inst., 79, 1341-1350 (1987).
35. MOSES, A.C., NISSLEY, S.P., PASSAMANI, J. and WHITE, R.M., Further characterization of growth hormone-dependent somatomedin-binding proteins produced by rat liver cells in culture. Endocrinology, 104, 536-546 (1979).
36. MUNSON, P.J. and RODBARD, D., Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239 (1980).
37. NICOLSON, G.L., Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp. Cell Res., 204, 171-180 (1993).
38. OSBORNE, C.K., CORONADO, E.B., KITTEN, L.J., ARTEAGA, C.L., FUQUA, S.A., RAMASHARMA, K., MARSHALL, M. and LI, C.H., Insulin like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol., 3, 1701-1709 (1989).
39. PAIK, S., Expression of IGF-I and II mRNA in breast tissue. Breast Cancer Res. Treat., 22, 31-38 (1992).
40. PEYRAT, J.P. and BONNETERRE, J., Type 1 IGF receptor in human breast diseases. Breast Cancer Res. Treat., 22, 59-67 (1992).
41. SCATCHARD, G., The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci.. 51, 660-672 (1949).
42. STRACKE, M.L , ENGEL, J.D., WILSON, L.W., RECHLER, M.M., LIOTIA, L.A. and SCHIFFMANN, E., The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J. biol. Chem., 264, 21544-21549 (1989).
43. TALLY, M., LI, C.H. and HALL, K., IGF-2 stimulated growth mediated by the somatomedin type 2 receptor. Biochem biophys. Res. Comm., 148, 811-816 (1987).
44. TOBIN, G., YEE, D., BRUNNER, N. and ROTWEIN, P., A novel insulin-like growth factor I messenger RNA is expressed in normal and tumor cells. Mol. Endocrinol., 4, 1914-1920 (1990).
45. YAMORI, T., IIZUKA, Y., TAKAYAMA, Y., NISHIYA, S., IWASHITA, S., YAMAZAKI, A., TAKATORI, T. and TSURUO, T., Insulin-like growth factor I rapidly induces tyrosine phosphorylation of Mr 150,000 and a Mr 160,000 protein in highly metastatic mouse colon carcinoma 26 NL-17 cells. Cancer Res., 51, 5859-5865 (1991).
46. YEE, D., The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res. Treat., 32, 85-95 (1994).
47. YEE, D., CULLEN, K.J., PAIK, S., PERDUE, J.F., LIPPMAN, M.E. and ROSEN, N., Insulin-like growth factor II expression in human breast cancer. Cancer Res., 48, 6691-6696 (1988).
48. YOUNG, J.A.T. and TROWSDALE, J., A processed pseudogene in an intron of the HLA-DPβ1 chain gene is a member of the nbosomal protein L32 gene family. Nucleic Acids Res., 13, 8883-8891 (1985).